More than half of patients that undergo cancer treatment are estimated to have had at least one potential drug-drug interaction. Here, Jasmine Martin, MSc, of the University of Liverpool, Liverpool, UK, talks about the purpose of the Cancer Drug Interactions website as a tool to assist healthcare professionals in treating patients, while ensuring significant interactions are avoided. Speaking at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK, Ms Martin outlines the importance of smart apps in the healthcare setting.
Content on www.vjoncology.com from BOPA 2018 is supported by Napp Pharmaceuticals Ltd
cancer-druginteractions.org: a comprehensive tool for HCPs
